Innovative Technology EndoQuest Robotics is developing a groundbreaking flexible endoluminal robotic system that aims to perform minimally invasive procedures through natural orifices, addressing a significant market need for less invasive surgical options in gastrointestinal medicine.

Strategic Partnerships The company has formed key collaborations with NVIDIA for integrating advanced protocols and with Omnivision to incorporate cutting-edge imaging technology, enhancing the capabilities and appeal of its robotic system to future buyers.

Funding Momentum With recent $42 million in C-1 financing led by prominent investors, EndoQuest is well-positioned financially to accelerate product development and bring its innovative surgical system closer to market readiness.

Market Focus Targeting the gastrointestinal and endoluminal surgery markets, EndoQuest addresses a growing trend towards minimally invasive procedures, offering compelling solutions to healthcare providers seeking advanced surgical tools.

Growth Potential As a company with approximately 51 to 200 employees and a revenue estimate between $25 million and $50 million, EndoQuest presents a significant opportunity for sales engagement with hospitals, surgical centers, and research institutions eyeing next-generation robotic surgical systems.